期刊
NATURE
卷 507, 期 7492, 页码 366-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nature12979
关键词
-
资金
- Deutsche Forschungsgemeinschaft [SFB-650, TRR-36, TRR-130, FI-1238/02, Do491/7-2, Do491/8-2]
- Hertie Stiftung
- Merieux Institute
- INRA
- CIHR/MSSC New Emerging Team grant in Clinical Autoimmunity
- UK Medical Research Council
- Wellcome Trust
- Clinical Competence Network for Multiple Sclerosis
- [SFB-TR128]
- MRC [G1100084, G0901697, G0801924] Funding Source: UKRI
- Medical Research Council [G1100084, G0801924, G0901697] Funding Source: researchfish
B lymphocytes have critical roles as positive and negative regulators of immunity. Their inhibitory function has been associated primarily with interleukin 10 (IL-10) because B-cell-derived IL-10 can protect against autoimmune disease and increase susceptibility to pathogens(1,2). Here we identify IL-35-producing B cells as key players in the negative regulation of immunity. Mice in which only B cells did not express IL-35 lost their ability to recover from the T-cell mediated demyelinating autoimmune disease experimental autoimmune encephalomyelitis (EAE). In contrast, these mice displayed a markedly improved resistance to infection with the intracellular bacterial pathogen Salmonella enterica serovar Typhimurium as shown by their superior containment of the bacterial growth and their prolonged survival after primary infection, and upon secondary challenge, compared to control mice. The increased immunity found in mice lacking IL-35 production by B cells was associated with a higher activation of macrophages and inflammatory T cells, as well as an increased function of B cells as antigen-presenting cells (APCs). During Salmonella infection, IL-35- and IL-10-producing B cells corresponded to two largely distinct sets of surface-IgM1 CD138(hi)TACI(+)CXCR4(+)CD1d(int)Tim1(int) plasma cells expressing the transcription factor Blimp1 (also known as Prdm1). During EAE, CD138(+) plasma cells were also the main source of B-cell-derived IL-35 and IL-10. Collectively, our data show the importance of IL-35 producing B cells in regulation of immunity and highlight IL-35 production by B cells as a potential therapeutic target for autoimmune and infectious diseases. This study reveals the central role of activated B cells, particularly plasma cells, and their production of cytokines in the regulation of immune responses in health and disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据